Qingyi Wei

机构：Duke University, Fudan University, South China University of Technology, Guangzhou Medical University · ORCID：0000-0002-3845-9445

发表论文 798 篇 · 总被引 30997 次 · h-index 82

代表论文

• Clinical efficacy of CDK4/6 inhibitor plus endocrine therapy in HR-positive/HER2-0 and HER2-low-positive metastatic breast cancer: a secondary analysis of PALOMA-2 and PALOMA-3 trials (2024 · EBioMedicine · 被引 28)
• CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility (2023 · Cancer Research · 被引 18)
• Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: a National Cancer Database Analysis (2023 · Breast Cancer Research and Treatment · 被引 14)
• Bacillus cereus GW-01 inoculation reduces pyrethroid residues and improves quality of Sichuan Paocai by changing the metabolic profile of fermentation (2024 · LWT · 被引 9)
• Appropriate dose of regorafenib based on body weight of colorectal cancer patients: a retrospective cohort study (2023 · BMC Cancer · 被引 9)
• Dual hydrogen-bond network-enhanced sensor of recycle SERS substrate using MXene/hydrogel for sensitive detection of malachite green residues in fish (2025 · Food Chemistry · 被引 6)